Optimizing the Use of Telemedicine in Oncology Care: Postpandemic Opportunities.
Karen E KnudsenCheryl WillmanRobert A WinnPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Utilization of telehealth as part of the cancer care delivery continuum dramatically escalated in response to the COVID-19 pandemic at major cancer centers across the globe. The rapid shift toward telehealth visits for nontreatment cancer care provided immediate benefit through reducing unnecessary risk of exposure, overcoming transportation barriers faced by both patients and caregivers, and fast-tracking care transformation. As such, delineating the impact of telehealth on access, health equity, quality, and outcomes will be essential for refining the use of digital strategies and telehealth toward optimizing cancer care. Herein, experiences to date with telehealth usage for oncology care are reviewed, and priorities are outlined for postpandemic opportunities to improve the lives of patients with cancer through telemedicine.
Keyphrases
- palliative care
- healthcare
- quality improvement
- end stage renal disease
- mental health
- chronic kidney disease
- public health
- ejection fraction
- pain management
- newly diagnosed
- papillary thyroid
- prognostic factors
- squamous cell carcinoma
- metabolic syndrome
- health information
- insulin resistance
- chronic pain
- patient reported outcomes
- weight loss
- skeletal muscle
- social media